Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

This study has been completed.

Sponsor:

Collaborator:

Shin Poong Pharmaceutical Co. Ltd.

Information provided by (Responsible Party):

Medicines for Malaria Venture

ClinicalTrials.gov Identifier:

NCT01594931

First received: May 7, 2012

Last updated: May 8, 2012

Last verified: May 2012

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2006
Primary Completion Date:	March 2006 (Final data collection date for primary outcome measure)

No publications provided by Medicines for Malaria Venture

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Duparc S, Borghini-Fuhrer I, Craft CJ, Arbe-Barnes S, Miller RM, Shin CS, Fleckenstein L. Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials. Malar J. 2013 Feb 21;12:70. doi: 10.1186/1475-2875-12-70.

To Top